2024 saw the rise of many generative AI applications in various industries, including healthcare, driving work and operational efficiencies like never before. 

It is also one of the technology solutions that came out of an accelerator programme by the National University of Singapore Yong Loo Lin School of Medicine and 22Health Ventures. Interestingly, the clinical AI copilot might have been named after an AI all too familiar to many fans of the Marvel Comics character Iron Man.

Mobihealth News spoke with Dr Nelson Lau, CEO and co-founder of HealthBridge AI, to get more details about JarvisMD and how it is set apart from a bunch of similar genAI innovations in healthcare. He also shared their plans for the new year. 

Q. When was your company founded and where is it based? Can you briefly describe your technology solution? 

A. Our company was founded in 2023 and our solution, JarvisMD is currently being used and tested by doctors in Australia. Our team is currently based globally across Southeast Asia, the United States, and Canada. 

JarvisMD is an audio-to-text transcription tool and an AI clinical copilot that solves the problem of doctor burnout.

Q. Just wondering: is JarvisMD inspired by or takes reference from Tony Stark’s J.A.R.V.I.S. in the Iron Man series? 

A. While we didn't draw direct inspiration from Iron Man, there's a wonderful parallel between Tony Stark's J.A.R.V.I.S and our vision for JarvisMD. Just as Jarvis serves as Stark's intelligent assistant, streamlining complex tasks and enhancing his capabilities, JarvisMD aims to be a doctor's trusted ally in tackling their greatest challenge: administrative workload. We've built an AI assistant that handles clinical documentation and delivers evidence-based insights, freeing physicians to focus on what matters most—caring for their patients. The name reflects our mission of using advanced technology to enhance medical professionals' effectiveness, much like how J.A.R.V.I.S enhances Stark's abilities in the movies.

Q. What inspired you to innovate? What are the main healthcare challenges you intend to address?

A. Having practised medicine for over three decades, I've experienced firsthand how administrative burdens drain physicians' time and energy, ultimately impacting both patient care and physician wellbeing. My longstanding passion for technology and its potential to revolutionise healthcare delivery made me eager to explore innovative solutions. When Minh, my co-founder and CTO, and I connected, we immediately recognised an opportunity to make a meaningful difference. Our shared vision focused on addressing these administrative challenges that I had grappled with throughout my career, knowing that solving them could transform the practice of medicine for doctors everywhere.

Doctors face an overwhelming amount of paperwork, with hours spent daily on clinical documentation and referral letters. This administrative burden not only contributes to burnout but also severely limits the time available for what matters most: providing personalised, high-quality patient care.

JarvisMD addresses these critical challenges in healthcare through two key innovations:

First, we tackle the administrative burden head-on. With physicians spending up to 50% of their time on paperwork, our advanced speech-to-text technology automates clinical summaries and referral letters, reducing administrative time by up to 70%. This gives doctors precious hours back each day for patient care and improved work-life balance. 

Second, we enhance clinical decision-making through our AI-powered clinical copilot. In today's rapidly evolving medical landscape, doctors need quick access to reliable information. Our system delivers personalised, evidence-based answers to clinical questions, enabling faster and more informed decisions at the point of care.

Our mission combines cutting-edge AI technology with a deep understanding of healthcare professionals' daily challenges, and by transforming medical workflows, we help doctors improve patient outcomes while reclaiming their own quality of life.

Q. Many AI copilots or doctor assistants have come to market. What is your unique technology proposition and how do you set yourself apart from the pack?

A. JarvisMD stands out from the competition by being much more than a transcription tool or first-generation AI scribe. While many competitors focus solely on basic administrative support, JarvisMD has already advanced into its second and third generation of innovation, delivering features that directly improve clinical decision-making, patient safety, and care quality.

Its second-generation clinical decision support goes beyond automating paperwork; it actively assists doctors with personalised, evidence-based insights that reduce clinical errors and improve patient safety. This is a significant advancement compared to tools that stop at documentation. In its third generation, JarvisMD introduces a contextual clinical search engine, allowing doctors to quickly find and apply evidence-based information within the context of a patient’s history. This feature addresses knowledge gaps and supports better clinical decisions, offering capabilities unmatched by competitors.

While competitors focus on administrative inefficiencies, JarvisMD is evolving into a true AI clinical copilot, combining automation, real-time clinical support, and predictive intelligence to transform both the way doctors work and how patients are cared for. This multi-generational approach ensures we not only address today’s challenges but actively shape the future of healthcare. 

JarvisMD isn’t just catching up to doctors’ needs – it’s anticipating them.

Q. Which development stage are you currently at? What can you share with us so far in terms of research (i.e. AI accuracy and effectiveness)? 

A. JarvisMD is currently being used and tested by a select group of specialist doctors in Australia, offering clinical decision support and a contextual clinical search engine, and we are in the process of validating its clinical accuracy and usefulness. Our speech-to-text technology has achieved over 95% accuracy in clinical settings, effectively handling medical terminology and diverse dictation styles. Early trials have demonstrated that JarvisMD helps to improve clinical decision-making and enables faster, evidence-based care. Doctors using JarvisMD report up to a 70% reduction in documentation time, allowing them to focus more on their patients.

Looking ahead, we're developing predictive risk scores as part of our roadmap to enable early intervention and improve patient outcomes. 

Q. Can you describe your target users and outcomes? Have you secured or are currently under any partnerships with hospitals or health facilities that are testing your solution, and if so, how is it going so far?

A. Our target users are healthcare professionals, primarily doctors and clinicians, who are burdened by excessive administrative work and need reliable, real-time clinical support to improve efficiency and patient care outcomes. 

We're currently in discussions with several hospitals and healthcare facilities to test and implement JarvisMD. Initial feedback has been very encouraging, with doctors recognising the potential for significant reductions in administrative workload and they also see value in the JarvisMD’s ability to support clinical decision-making. These ongoing discussions allow us to validate JarvisMD’s effectiveness and further refine the solution based on real-world needs. 

Q. What can you share with us regarding your plans for the new year? Any market commercialisation/expansion targets?

A. In the new year, we are focused on launching and expanding JarvisMD across Australia, our initial key market. We aim to partner with hospitals, clinics, and healthcare systems. Following our launch in Australia, we plan to expand into Southeast Asia, where there is a growing demand for innovative tools to support healthcare efficiency and outcomes.

_

Responses have been edited for clarity and brevity.